Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.9750
+0.0150
+(1.56%)
As of 2:09:13 PM GMT+1. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jonas Sohlman | Chief Executive Officer | 1.07M | -- | 1965 |
| Mr. Jan Persson | Chief Financial Officer | -- | -- | -- |
| Mr. Patrik Hellberg | Chief Investment Officer | -- | -- | -- |
| Dr. Andrew Waller | Chief Scientific Officer | -- | -- | -- |
Intervacc AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Intervacc AB (publ) develops novel veterinary vaccines for animals in Sweden. The company's product pipeline includes Stangvac, a vaccine against equine strangles for horses; INV274, antigens for a vaccine against Strep. suis for the treatment of piglets; and INV412, a multi-component vaccine to protect against several bacteria which cause mastitis for treating cows. It also engages in marketing and distribution of veterinary products in the Nordic markets, which includes vaccines and pharmaceuticals for swine, horses, cattle, and sheep. The company was incorporated in 1983 and is based in Hägersten, Sweden.
Corporate Governance
Intervacc AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 14, 2025 at 10:59 AM UTC
Intervacc AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
DIABIO.ST Diagonal Bio AB (publ)
0.0165
-4.07%
FARN.L Faron Pharmaceuticals Oy
169.00
+0.90%
EGTX.ST Egetis Therapeutics AB (publ)
5.02
0.00%
GENO.ST Genovis AB (publ.)
29.10
+2.11%
NANOFH.HE Nanoform Finland Oyj
1.2500
+2.29%
DMYD-B.ST Diamyd Medical AB (publ)
15.82
+3.81%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
27.60
+1.47%
SANION.ST Saniona AB (publ)
8.00
0.00%
ONCO.ST Oncopeptides AB (publ)
1.8580
+1.09%
FARON.HE Faron Pharmaceuticals Oy
1.9980
-1.82%